Publications by authors named "Pedro Malavet"
High overlap in patients diagnosed with hypermobile Ehlers-Danlos syndrome or hypermobile spectrum disorders with fibromyalgia and 40 self-reported symptoms and comorbidities.
Front Med (Lausanne)
April 2023
Article Synopsis
- Joint pain is a prevalent issue for patients with hypermobile Ehlers-Danlos Syndrome (hEDS), hypermobility spectrum disorders (HSD), and fibromyalgia, prompting a study to analyze overlapping symptoms among these conditions.
- The study analyzed data from 733 patients at an EDS Clinic, revealing that a significant majority (56.5%) had both hEDS/HSD and fibromyalgia, with high symptom overlap reported across 40 different symptoms.
- Key findings indicate patients with only hEDS/HSD experience fewer symptoms compared to those with both diagnoses, with the most notable issues for those with hEDS/HSD and fibromyalgia including joint pain, subluxations, and a significantly higher impact on daily activities.
Objective: To assess the association between vitamin B12 (B12) deficiency and the prevalence of fatigue and prespecified neurologic symptoms in patients with fibromyalgia.
Patients And Methods: A retrospective chart analysis of patients diagnosed with fibromyalgia in the years 2015-2020 was performed. The values of B12 were collected.
Objective: Routine medical testing is not recommended before cataract surgery, but no consensus exists about preoperative testing before general ophthalmologic surgery. We aimed to assess the impact of preoperative testing on patients undergoing ophthalmologic surgery by analyzing their surgical outcomes and complications.
Methods: We retrospectively reviewed electronic health records of patients who had preoperative evaluations before cataract or noncataract ophthalmologic surgery at a tertiary care center from January 1, 2015, through December 31, 2019.
Objective: We aimed to review recommendations for the postoperative resumption of direct oral anticoagulants (DOACs) and report complications 30 days postoperatively.
Methods: We retrospectively reviewed patients receiving DOAC therapy who underwent preoperative evaluations from January 1, 2015 through May 30, 2018. We noted days that DOAC therapy was withheld, postoperative time until resumption of the DOAC, and complications within 30 postoperative days.